News
The low-cost test developed by Professor Vinayak Dravid and research professor Gajendra Shekhawat builds on an existing ...
18h
GlobalData on MSNRallybio drops drug for rare maternal disorder following Phase II failAfter dropping the FNAIT therapy, Rallybio will prioritise another candidate that is being investigated in complement-driven diseases.
Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells.
Immunotherapy has revolutionized the way physicians treat patients with cancer. This form of cancer treatment aims to direct the immune system toward the r | Immunology ...
Researchers have developed new technology that could lead to the creation of a rapid point-of-care test for HIV infection competitive with traditional lab-based HIV testing in a fraction of ...
2d
AZoOptics on MSNUsing High-Speed Atomic Force Microscopy to Improve Biomarker DiscoveryHigh-speed atomic force m (HS-AFM) reveals nanoscale differences in small extracellular vesicles (sEVs), improving biomarker ...
The development of HIV-specific IgA responses with affinity maturation have been shown to in ... Current common strategies to generate antigen specific antibodies and evaluating humoral vaccine ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
In the landmark Amgen v. Sanofi case (previously covered here), the Supreme Court affirmed that patent claims drawn to a genus of ...
Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of ...
Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results